Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerardo Ferrer

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Scientific Reports|August 26, 2018
Electrophilic nitroalkene-tocopherol derivatives: synthesis, physicochemical characterization and evaluation of anti-inflammatory signaling responsesJorge Rodriguez-Duarte, Rosina Dapueto, Germán Galliussi, et al.
Frontiers in Oncology|April 3, 2023
CLL stereotyped B-cell receptor immunoglobulin sequences are recurrent in the B-cell repertoire of healthy individuals: Apparent lack of central and early peripheral tolerance censoringStefano Vergani, Davide Bagnara, Andreas Agathangelidis, et al.
JCI Insight|May 5, 2022
Activated CLL cells regulate IL-17F-producing Th17 cells in miR155-dependent and outcome-specific mannersByeongho Jung, Gerardo Ferrer, Pui Yan Chiu, et al.
Free Radical Biology & Medicine|June 1, 2015
A comprehensive evaluation of catalase-like activity of different classes of redox-active therapeuticsArtak Tovmasyan, Clarissa G C Maia, Tin Weitner, et al.
Scientific Reports|September 16, 2016
Catalytic Thr or Ser Residue Modulates Structural Switches in 2-Cys Peroxiredoxin by Distinct MechanismsCarlos A Tairum, Melina Cardoso Santos, Carlos A Breyer, et al.
JCI Insight|May 10, 2016
Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6-deficient processPiers E M Patten, Gerardo Ferrer, Shih-Shih Chen, et al.
The Journal of Clinical Investigation|November 23, 2021
B cell receptor isotypes differentially associate with cell signaling, kinetics, and outcome in chronic lymphocytic leukemiaAndrea N Mazzarello, Eva Gentner-Göbel, Marcus Dühren-von Minden, et al.
Cancer Research Communications|February 1, 2024
Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating TherapyIgnacio Campillo-Marcos, Marta Casado-Pelaez, Veronica Davalos, et al.
Leukemia|January 28, 2021
Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic targetFlorencia Palacios, Xiao-Jie Yan, Gerardo Ferrer, et al.
Haematologica|February 20, 2025
Chronic lymphocytic leukemia often arises by a multiclonal selection processDavide Bagnara, Andrea N Mazzarello, Niccolò Cardente, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Scientific Reports|August 26, 2018
Electrophilic nitroalkene-tocopherol derivatives: synthesis, physicochemical characterization and evaluation of anti-inflammatory signaling responsesJorge Rodriguez-Duarte, Rosina Dapueto, Germán Galliussi, et al.
Frontiers in Oncology|April 3, 2023
CLL stereotyped B-cell receptor immunoglobulin sequences are recurrent in the B-cell repertoire of healthy individuals: Apparent lack of central and early peripheral tolerance censoringStefano Vergani, Davide Bagnara, Andreas Agathangelidis, et al.
JCI Insight|May 5, 2022
Activated CLL cells regulate IL-17F-producing Th17 cells in miR155-dependent and outcome-specific mannersByeongho Jung, Gerardo Ferrer, Pui Yan Chiu, et al.
Free Radical Biology & Medicine|June 1, 2015
A comprehensive evaluation of catalase-like activity of different classes of redox-active therapeuticsArtak Tovmasyan, Clarissa G C Maia, Tin Weitner, et al.
Scientific Reports|September 16, 2016
Catalytic Thr or Ser Residue Modulates Structural Switches in 2-Cys Peroxiredoxin by Distinct MechanismsCarlos A Tairum, Melina Cardoso Santos, Carlos A Breyer, et al.
JCI Insight|May 10, 2016
Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6-deficient processPiers E M Patten, Gerardo Ferrer, Shih-Shih Chen, et al.
The Journal of Clinical Investigation|November 23, 2021
B cell receptor isotypes differentially associate with cell signaling, kinetics, and outcome in chronic lymphocytic leukemiaAndrea N Mazzarello, Eva Gentner-Göbel, Marcus Dühren-von Minden, et al.
Cancer Research Communications|February 1, 2024
Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating TherapyIgnacio Campillo-Marcos, Marta Casado-Pelaez, Veronica Davalos, et al.
Leukemia|January 28, 2021
Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic targetFlorencia Palacios, Xiao-Jie Yan, Gerardo Ferrer, et al.
Haematologica|February 20, 2025
Chronic lymphocytic leukemia often arises by a multiclonal selection processDavide Bagnara, Andrea N Mazzarello, Niccolò Cardente, et al.
Pageof 9